ORLANDO, Fla. (April 30, 2020) – Telemedicine is poised to become a mainstream alternative to the traditional in-person methods of care delivery, with the COVID-19 pandemic easing barriers to acceptance… Read More »
Read MoreNasal drug repurposing has seen a real resurgence recently, driven by several factors. From an economic perspective, partners benefit from reduced development costs, intellectual property (IP) creation, increased market share… Read More »
Read MoreFOR IMMEDIATE RELEASE CONTACT: Carolyn Reis, APR, at Carolyn@ReisCorporatePR.com or (407) 590-0251 ORLANDO, Fla. (February 10, 2020) — Noble International, an industry leader in developing training devices and onboarding solutions… Read More »
Read MoreDiagnoses of chronic illnesses such as rheumatoid arthritis (RA), Crohn’s disease and osteoporosis are expected to skyrocket in the coming decade, resulting in growing use of patient-centric drug delivery devices… Read More »
Read MoreIn the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn… Read More »
Read MoreAptar Pharma, a leading drug delivery systems provider, announces its Platinum Sponsorship of this year’s Drug Delivery to the Lung (DDL) Conference 2019, which takes place from December 11-13 in… Read More »
Read MoreCrystal Lake, Illinois, October 31, 2019 – AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, announced today that, subsequent to the end… Read More »
Read MoreLast year, Medgadget heard from Noble International about its smart training devices that educate patients on safe and effective at-home use of prefilled syringes and autoinjectors. At the time, Joe Reynolds, Research Manager… Read More »
Read MoreA primary goal of rheumatologists remains alleviating the pain, stiffness and tenderness that mark rheumatoid arthritis (RA). Yet in an era marked by a significant increase in self-injection options,… Read More »
Read MoreMillions of patients worldwide living with rare, debilitating conditions are benefiting from developments in biopharmaceuticals and complex chemical entities as well as novel approaches to drug delivery. For example,… Read More »
Read More